
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services Inc. has demonstrated significant financial performance, with its Acute Care Hospital Services segment achieving a year-over-year adjusted EBITDA margin expansion of 190 basis points to 15.8%. The Behavioral Health Services segment reported a revenue growth of 9.3%, complemented by an 8.5% increase when excluding certain volumes, indicating a positive trend in patient engagement. Additionally, the company anticipates potential additional benefits of $75-80 million from pending CMS program approvals, combined with strong pricing and revenue growth projections that suggest future profitability may outpace costs.
Bears say
The analysis highlights several factors contributing to a negative outlook on Universal Health Services's stock, particularly concerning revenue projections and operational headwinds. Key metrics indicate that fiscal year 2026 earnings may be approximately 5% below estimates due to volume and margin pressures, compounded by a downward adjustment in long-term growth expectations for behavioral health services. Furthermore, the anticipated decline in EBITDA contributions from the DPP segment and potential risks related to regulatory changes and labor market constraints add further strain on the company’s financial stability and operational efficiency.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares